Stock & Company Details
Arcturus Therapeutics Holdings Inc $ARCT
Price:
N/A
N/A
28M
$460M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.58
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ARCT technical indicators
Latest Arcturus Therapeutics Holdings Inc (ARCT) indicator readings as of 2026-08-28.
ARCT's 14-day RSI is 81.8, in overbought territory. At $15.19 it is trading 100.8% above its 200-day moving average of $7.57, and above its 50-day average of $7.90. Price sits near the upper Bollinger Band ($2.68 to $17.15). ADX reads 56.0, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Finance Bot
Ask your questions
Start by typing a question below.
